Case Study: Biotechnology Company achieves greater supply chain efficiency with Kinaxis

How a global biotherapeutics company leveraged supply chain optimization for greater automation and efficiency

The Biotechnology Company is a global biotherapeutics leader in plasma therapeutics, operating a “vein to vein” supply chain across more than 40 countries. It needed to automate co-product demand-driven recipe selection and optimize plasma-based therapy production, moving beyond a manual Excel-based planning process that limited scenario analysis and increased inventory risk. Kinaxis Maestro® was used to improve demand and supply planning.

Kinaxis implemented supply chain optimization to account for material availability, capacity, co-product yields, facility constraints, plasma quality, and product demand. As a result, the company can generate multiple long-horizon scenarios in less than a minute, choose the best plasma fractionation options, improve response during COVID-19 disruptions, and reduce inventory and demand at risk while maximizing the use of scarce human plasma.